Figure 3From: The synergistic inhibitory effect of somatostatin-doxorubicin co-treatment on gallbladder carcinomaInhibition of gallbladder cancer xenograft growth on nude mice upon treatment with SST (1 mg/kg), DOX (2 mg/kg), or a combination of both (2 mg/kg DOX with either 1 mg/kg or 2 mg/kg SST). Means that are significantly different from the control group are indicated with an asterisk (P < 0.05).Back to article page